![]() |
||||||||||
|
||||||||||
![]() |
||||||||||
Complementary Medicine - CamTopic ContentsWarfarinDrug InformationWarfarin is an anticoagulant (slows blood clotting) used to prevent and treat people with venous thrombosis (blood clots in the veins) and pulmonary embolism (blood clots in the lungs). Warfarin is also used to treat or prevent dangerous blood clotting in people with atrial fibrillation (an irregularity in heartbeat) and, in some cases, to prevent stroke . Common brand names:Coumadin, JantovenSummary of Interactions with Vitamins, Herbs, & Foods
Types of interactions:
Beneficial
Adverse
Check
Replenish Depleted Nutrients
Reduce Side Effects
Support Medicine
Reduces Effectiveness
Potential Negative Interaction
Explanation Required
The Drug-Nutrient Interactions table may not include every possible interaction. Taking medicines with meals, on an empty stomach, or with alcohol may influence their effects. For details, refer to the manufacturers’ package information as these are not covered in this table. If you take medications, always discuss the potential risks and benefits of adding a new supplement with your doctor or pharmacist.
References1. Morton RA. Ubiquinones, plastoquinones and vitamins K. Biol Rev Camb Philos Soc 1971;46:47–96. 2. Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344:1372–3 [letter]. 3. Combs AB, Porter TH, Folkers K. Anticoagulant activity of a naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q10-enzyme systems. Res Commun Chem Pathol Pharmacol 1976;13:109–14. 4. Landbo C, Almdal TP. Interaction between warfarin and coenzyme Q10. Ugeskr Laeger 1998;160:3226–7 [in Danish]. 5. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother 1999;33:426–8. 6. Pinto JT. The pharmacokinetic and pharmacodynamic interactions of foods and drugs. Topics in Clinical Nutrition 1991;6:14–33. 7. Pinto JT. The pharmacokinetic and pharmacodynamic interactions of foods and drugs. Topics in Clinical Nutrition 1991;6:14–33. 8. Mauer A, Johne A, Bauer S, et al. Interaction of St. John’s wort extract with phenprocoumon [abstract]. Eur J Clin Pharmacol 1999;55:A22. 9. Safety of St. John’s wort (Hypericum perforatum)[letters, various authors]. Lancet 2000;355:575–7. 10. Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St. John’s wort and theophylline [letter]. Ann Pharmacother 1999;33:502. 11. Mai I, Schmider J, et al. Unpublished results, May 1999. Reported in: Johne A, Brockmöller J, Bauer S, et al. Pharmacokinetic interaction of digoxin with an herbal extract from St. John’s wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338–45. 12. Pinto JT. The pharmacokinetic and pharmacodynamic interactions of foods and drugs. Topics in Clinical Nutrition 1991;6:14–33. 13. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med 2004;141:23–7. 14. No authors listed. Possible interaction between warfarin and cranberry juice. Curr Prob Pharmacovigilance 2003;29:8. 15. Yu CM, Chan JC, Sanderson JE. Chinese herbs and warfarin potentiation by “danshen.”J Intern Med 1997;241:337–9. 16. Tam LS, Chan TY, Leung WK, Critchley JA. Warfarin interactions with Chinese traditional medicines: Danshen and methyl salicylate medicated oil. Aust NZ J Med 1995;25:258. 17. Chan TY. Drug interactions as a cause of overanticoagulation and bleedings in Chinese patients receiving warfarin. Int J Clin Pharmacol Ther 1998;36:403–5. 18. Izzat MB, Yim AP, El-Zufari MH. A taste of Chinese medicine! Ann Thorac Surg 1998;66:941–2. 19. Brandin H, Myrberg O, Rundlof T, et al. Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy. Eur J Clin Pharmacol 2007;63:565–70. 20. Brinker F. Herb Contraindications and Drug Interactions. Sandy, OR: Eclectic Medical Publications, 1998,166–9. 21. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997;54:692–3. 22. Lee SH, Ahn YM, Ahn SY, et al. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008;14:715–21. 23. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51:175–80. 24. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51:175–80. 25. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991–1995). Drug Saf 1997;17:342–56. 26. Page RL, Lawrence JD. Potentiation of warfarin by dong quai. Phamacotherapy 1999;19:870–6. 27. Heptinstall S, Groenewegen WA, Spangenberg P, Loesche W. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol 1987;39:459–65. 28. Heptinstall S, Groenewegen WA, Spangenberg P, Losche W. Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia Haematol Int Mag Klin Morphol Blutforsch 1988;115:447–9. 29. Loesche W, Mazurov AV, Voyno-Yasenetskaya TA, et al. Feverfew—an antithrombotic drug? Folia Haematol Int Mag Klin Morphol Blutforsch 1988;115:181–4. 30. Rose KD, Croissant PD, Parliment CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report. Neurosurgery 1990;26:880–2. 31. Gadkari JV, Joshi VD. Effect of ingestion of raw garlic on serum cholesterol level, clotting time and fibrinolytic activity in normal subjects. J Postgrad Med 1991;37:128–31. 32. Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconst Surg 1995;95:213. 33. Sunter WH. Warfarin and garlic. Pharm J 1991;246:722 [letter]. 34. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: The Pharmaceutical Press, 1996, 135–7. 35. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992;340:1136–9. 36. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997;336:1108. 37. Rowin J, Lewis SL. Spontaneous bilateral subdural hematoma with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775–6. 38. Mathews MK. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998;50:1934. 39. Gilbert GJ. Ginkgo biloba. Lancet 1997;1137 [letter]. 40. Miller LG, Murray WJ, eds. Herbal Medicinals: A Clinician’s Guide. New York: Pharmaceutical Products Press, 1999, 313–5. 41. Lam AY, Elmer GW, Mohutsky MA. Possible interaction between warfarin and Lycium barbarum L. Ann Pharmacother 2001;35:1199–201. 42. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991–1995). Drug Saf 1997;17:342–56. 43. Wong ALN, Chan TYK. Interaction between warfarin and the herbal product quilinggao. Ann Pharmacother 2003;37:836–8. 44. Schrogie JJ. Coagulopathy and fat soluble vitamins. JAMA 1975;232:19 [letter]. 45. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and applications. J Am Diet Assoc 1995;95:580–4. 46. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997;54:692–3. 47. Lee SH, Ahn YM, Ahn SY, et al. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008;14:715–21. 48. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51:175–80. 49. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51:175–80. 50. Hanselin MR. Vande Griend JP, Linnebur SA. INR elevation with maitake extract in combination with warfarin. Ann Pharmacother 2010;44:223–4. 51. Food additives for direct addition to food for human consumption; olestra; final rule. 21 Federal Register 1996:3118–73. 52. Harrell CC, Kline SS. Vitamin K-supplemented snacks containing olestra: implication for patients taking warfarin. JAMA 1999;282:1133–4. 53. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and applications. J Am Diet Assoc 1995;95:580–4. 54. Rosenthal G. Interaction of ascorbic acid and warfarin. JAMA 1971;215:1671. 55. Taylor CT, Chester EA, Byrd DC, Stephens MA. Vitamin K to reverse excessive anticoagulation: A review of the literature. Pharmacotherapy 1999;19:1415–25. 56. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and applications. J Am Diet Assoc 1995;95:580–4. 57. Kodaka K, Ujiie T, Ueno T, Saito M. Contents of vitamin K1 and chlorophyll in green vegetables. J Jpn Soc Nutr Food Sci 1986;39:124–6. 58. Booth SL, Centurelli MA. Vitamin K: a practical guide to the dietary management of patients on warfarin. Nutr Rev 1999;57:288–96 [review]. 59. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med 1997;125:959–62. 60. Reese AM, Farnett LE, Lyons RM, et al. Low-dose vitamin K to augment anticoagulation control. Pharmacotherapy2005;25:1746–51. 61. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007;109:2419–23. 62. Rombouts EK, Rosendaal FR, Van Der Meer FJM. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 2007;5:2043–8. 63. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and application. J Am Diet Assoc 1995;95:580–4. 64. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 293. 65. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 66. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 67. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother2002;36:1893–6. 68. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Ann Pharmacother 2002;36:940–1. 69. Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005;39:744–7. 70. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and application. J Am Diet Assoc 1995;95:580–4. 71. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 293. 72. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 73. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 74. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother2002;36:1893–6. 75. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Ann Pharmacother 2002;36:940–1. 76. Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005;39:744–7. 77. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and application. J Am Diet Assoc 1995;95:580–4. 78. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 293. 79. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 80. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 81. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother2002;36:1893–6. 82. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Ann Pharmacother 2002;36:940–1. 83. Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005;39:744–7. 84. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and application. J Am Diet Assoc 1995;95:580–4. 85. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 293. 86. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 87. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 88. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother2002;36:1893–6. 89. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Ann Pharmacother 2002;36:940–1. 90. Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005;39:744–7. 91. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and application. J Am Diet Assoc 1995;95:580–4. 92. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 293. 93. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 94. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 95. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother2002;36:1893–6. 96. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Ann Pharmacother 2002;36:940–1. 97. Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005;39:744–7. 98. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and application. J Am Diet Assoc 1995;95:580–4. 99. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 293. 100. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 101. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5. 102. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother2002;36:1893–6. 103. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Ann Pharmacother 2002;36:940–1. 104. Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005;39:744–7.
Last Review: 11-07-2012 Copyright © 2012 Aisle7. All rights reserved. Aisle7.com Please read the disclaimer about the limitations of the information provided here. Do NOT rely solely on the information in this article. The Aisle7 knowledgebase does not contain every possible interaction. Learn more about Aisle7, the company. The information presented in Aisle7 is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires June 2013. This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. |
||
|
||||||

